Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De

Showing results (11-20 of 54,288) with videos related to

Pageof 5,429
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|July 1, 1998
[Group B Streptococcus infections: new forms. New preventive measures]M de Cueto, M de la Rosa-Fraile
Revista De Saude Publica|October 1, 1995
[Models of causal inference: critical analysis of the use of statistics in epidemiology]D Czeresnia, M de Fátima, M de Albuquerque
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|October 1, 1993
Phosphoinositide phosphorylation and shape changes produced by phosmet-oxon in human erythrocytesG M de Potás, A M de D'Angelo
Cancer Treatment Reports|May 1, 1977
Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinomaG M De Palo, M De Lena, G Bonadonna
Tumori|July 1, 1973
[Cytostatic therapy of pleural effusion caused by metastatic carcinoma of the breast (author's transl)]G M De Palo, G Beretta, M De Lena
Memorias Do Instituto Oswaldo Cruz|April 1, 1992
Endocytosis of albumin-gold particles by Trypanosoma cruzi infected and non infected heart muscle cellsM de N Soeiro, M de N De Meirelles
Journal of Protein Chemistry|February 24, 2001
Effects of denaturing and stabilizing agents on the inhibitory activity and conformational stability of Schizolobium parahyba chymotrypsin inhibitorE M de Souza, R C Teles, E M de A Siqueira, et al.
BMJ (Clinical Research Ed.)|June 22, 2001
Medical errors. Chemotherapy regimens have been formalised into protocols in British ColumbiaM de Lemos
Clinical and Experimental Rheumatology|December 5, 2002
Standard and innovative therapy of inflammatory bowel diseasesM De Vos
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 21, 1999
[Autologous transfusion: when best should not be the enemy of good enough...]M de Montalembert
Pageof 5,429

Showing results (11-20 of 54,288) with videos related to

Sort By:
Pageof 5,429
Enfermedades Infecciosas Y Microbiologia Clinica|July 1, 1998
[Group B Streptococcus infections: new forms. New preventive measures]M de Cueto, M de la Rosa-Fraile
Revista De Saude Publica|October 1, 1995
[Models of causal inference: critical analysis of the use of statistics in epidemiology]D Czeresnia, M de Fátima, M de Albuquerque
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|October 1, 1993
Phosphoinositide phosphorylation and shape changes produced by phosmet-oxon in human erythrocytesG M de Potás, A M de D'Angelo
Cancer Treatment Reports|May 1, 1977
Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinomaG M De Palo, M De Lena, G Bonadonna
Tumori|July 1, 1973
[Cytostatic therapy of pleural effusion caused by metastatic carcinoma of the breast (author's transl)]G M De Palo, G Beretta, M De Lena
Memorias Do Instituto Oswaldo Cruz|April 1, 1992
Endocytosis of albumin-gold particles by Trypanosoma cruzi infected and non infected heart muscle cellsM de N Soeiro, M de N De Meirelles
Journal of Protein Chemistry|February 24, 2001
Effects of denaturing and stabilizing agents on the inhibitory activity and conformational stability of Schizolobium parahyba chymotrypsin inhibitorE M de Souza, R C Teles, E M de A Siqueira, et al.
BMJ (Clinical Research Ed.)|June 22, 2001
Medical errors. Chemotherapy regimens have been formalised into protocols in British ColumbiaM de Lemos
Clinical and Experimental Rheumatology|December 5, 2002
Standard and innovative therapy of inflammatory bowel diseasesM De Vos
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 21, 1999
[Autologous transfusion: when best should not be the enemy of good enough...]M de Montalembert
Pageof 5,429